Clinical Trials
49 trialsHarvesting Cells for Experimental Cancer Treatments
National Institutes of Health Clinical Center (CC)
CER
Cancer Support Community, Research and Training Institute, Philadelphia
ELEPHAS-04
Mayo Clinic
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
N-Power Medicine
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
University of Oklahoma
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
Mayo Clinic
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
ARIS
Hopitaux Prives de Metz, Groupe UNEOS
START
Lyell Immunopharma, Inc.
LOLA-PROJECT
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Integrin αvβ6-targeted PET in Malignant Tumors
Zhongnan Hospital
CA209-1529
D'Or Institute for Research and Education
PROFIL-1
University Hospital, Brest
FINN
Bristol-Myers Squibb
Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment
Daiichi Sankyo
The Impact of Radiotherapy on Oligometastatic Cancer
Institut Investigacio Sanitaria Pere Virgili
LUTON
Hospices Civils de Lyon
LORLAPULM
Fundación GECP
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Repertoire Immune Medicines
Impact of ctDNA in Cancer Early Detection and STAS Evaluation in Patients With GGOs
University of Roma La Sapienza
SPACE2
Weprom
NEPTUN
iOMEDICO AG
CHAPLIN
iOMEDICO AG
Whole-Exome Sequencing (WES) of Cancer Patients
Dana-Farber Cancer Institute
PIONEER
SpeciCare
I-SABR2_PDA
Maastricht University
PROXie
iOMEDICO AG
REVEAL
AstraZeneca
SPECIALK
Fondazione Ricerca Traslazionale
Establishment of a PDT Patient Registry
Concordia Laboratories Inc.
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
SWOG Cancer Research Network
CANPOS
Hospices Civils de Lyon
LCLC
Shanghai 10th People's Hospital
Validation of a Kinetic Model of Erlotinib
University Hospital, Strasbourg, France
Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
Case Comprehensive Cancer Center
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
Case Comprehensive Cancer Center
LYMPHOS1
Centre Leon Berard
PFS
University of Iowa
Characterization of Brain Metastases
Norwegian University of Science and Technology
Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
National Cancer Institute (NCI)
Study of Episodic Breathlessness in Patients With Lung Cancer or Other Advanced Disease
National Cancer Institute (NCI)
FRAME
Eli Lilly and Company
Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer
National Institute of Cancerología
Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.
Norwegian University of Science and Technology
Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
University of New Mexico
Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia
National Cancer Institute (NCI)
Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)
Amgen
Molecular Mechanism of Trophinin in Cancer Invasion and Metastasis
National Taiwan University Hospital